• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含低剂量乙炔雌二醇和孕二烯酮的单相复方避孕药在青少年中的临床耐受性

Clinical tolerance of a combined monophasic contraceptive agent containing a low-dose of ethinyloestradiol and gestodene in adolescents.

作者信息

Leonard F, Gaspard U, Theunissen L

机构信息

Department of Gynaecology, University of Liège, CHU Sart Tilman, Belgium.

出版信息

Curr Med Res Opin. 1993;13(2):78-86. doi: 10.1185/03007999309111536.

DOI:10.1185/03007999309111536
PMID:8325045
Abstract

The clinical effects and the contraceptive effectiveness of a monophasic preparation containing 30 micrograms ethinyloestradiol and 75 micrograms gestodene per tablet were assessed in a study of 115 healthy adolescents (mean age 18.5 +/- 2 years) covering a total of 712 menstrual cycles (mean of 8 cycles per patient). There was a number of cases of discontinuation of the study (70/115), mainly due to poor discipline in tablet intake in this particular age group. Only 20 cases discontinued the study for medical reasons. No pregnancies occurred, in spite of the fact that tablets were frequently forgotten (11% of cycles). Eighty-eight percent of cycles presented a normal bleeding pattern from the second month of treatment on. Spotting was sporadic (less than 8% from the 2nd cycle) and was mainly associated with tablet omission. Intermenstrual bleeding (breakthrough bleeding) occurred in 19% of the first menstrual cycles but only in 5% of the second and following cycles. Tenderness of the breast was the most frequent subjective complaint (3.4% of cycles), followed by urogenital problems, headaches and digestive disorders. However, all complaints remained sporadic (13.4% of cycles). The systolic blood pressure showed little variation, with only a slight increase from 123 to 125 mmHg after 6 months of treatment. Though not clinically important, an increase in diastolic blood pressure was observed (from 76 to 82 mmHg after 6 months). The patients showed a tendency to increase weight (from 54.4 to 56.7 kg after 6 months.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在一项针对115名健康青少年(平均年龄18.5±2岁)的研究中,评估了一种每片含30微克乙炔雌二醇和75微克孕二烯酮的单相制剂的临床效果和避孕效果,该研究涵盖了总共712个月经周期(每位患者平均8个周期)。有许多例研究中断情况(70/115),主要是由于这个特定年龄组服药纪律差。只有20例因医学原因中断研究。尽管经常忘记服药(11%的周期),但未发生妊娠。从治疗第二个月起,88%的周期呈现正常出血模式。点滴出血是偶发的(从第2个周期起少于8%),主要与漏服药物有关。月经间期出血(突破性出血)在第一个月经周期中发生率为19%,但在第二个及后续周期中仅为5%。乳房压痛是最常见的主观症状(3.4%的周期),其次是泌尿生殖系统问题、头痛和消化系统紊乱。然而,所有症状仍为偶发(13.4%的周期)。收缩压变化不大,治疗6个月后仅从123 mmHg略有升至125 mmHg。虽然在临床上不重要,但观察到舒张压有所升高(6个月后从76 mmHg升至82 mmHg)。患者有体重增加的趋势(6个月后从54.4 kg增至56.7 kg)。(摘要截选至250词)

相似文献

1
Clinical tolerance of a combined monophasic contraceptive agent containing a low-dose of ethinyloestradiol and gestodene in adolescents.含低剂量乙炔雌二醇和孕二烯酮的单相复方避孕药在青少年中的临床耐受性
Curr Med Res Opin. 1993;13(2):78-86. doi: 10.1185/03007999309111536.
2
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.一项为期十二个月的比较临床研究,针对两种低剂量口服避孕药,分别含有20微克炔雌醇/75微克孕二烯酮和30微克炔雌醇/75微克孕二烯酮,研究其有效性、周期控制和耐受性。
Contraception. 1997 Mar;55(3):131-7. doi: 10.1016/s0010-7824(97)00025-5.
3
Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.年轻女性使用三相口服避孕药(“Trinordiol”)的临床经验。
Curr Med Res Opin. 1983;8(6):395-404. doi: 10.1185/03007998309111745.
4
Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.两种低剂量口服避孕药敏定偶和美欣乐在30岁以上女性中的临床比较。
Contraception. 1994 Jan;49(1):33-46. doi: 10.1016/0010-7824(94)90107-4.
5
Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.一项关于含有炔雌醇和去氧孕烯的单相口服避孕药的多中心试验。
Acta Obstet Gynecol Scand. 1988;67(2):171-4. doi: 10.3109/00016348809004193.
6
Long-term experience with a low-dose oral contraceptive.低剂量口服避孕药的长期使用经验。
Gynecol Endocrinol. 1990 Dec;4(4):277-86. doi: 10.3109/09513599009024982.
7
Open prospective multicenter trial with a new monophasic contraceptive combination containing gestodene.
Contraception. 1991 May;43(5):413-21. doi: 10.1016/0010-7824(91)90132-y.
8
Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.两种口服避孕药制剂的可靠性、周期控制及副作用比较概况,这两种制剂含150微克去氧孕烯及30微克或20微克炔雌醇。
Br J Obstet Gynaecol. 1993 Sep;100(9):832-8. doi: 10.1111/j.1471-0528.1993.tb14309.x.
9
Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.在泰国女性中进行的两种含30微克炔雌醇及去氧孕烯或孕二烯酮单相口服避孕药的多中心试验。
Contraception. 1995 Apr;51(4):225-9. doi: 10.1016/0010-7824(95)00037-b.
10
Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.一项多中心临床研究中两种低剂量口服避孕药的疗效、周期控制及耐受性比较
Contraception. 1999 Nov;60(5):269-74. doi: 10.1016/s0010-7824(99)00097-9.